Skip to main content

Targeting the brain sigma-1 receptor: A paradigm shift for the treatment of neuro-degenerative disorders

Project description

Drug repurposing for the treatment of neurodegenerative diseases

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Coordinator

SIGMATHERA SAS
Address
Agropolis 2, 2196 Boulevard De La Lironde
34980 Montferrier Sur Lez
France
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000